Document Detail

Human recombinant interleukin-1 alpha is proinflammatory in normal human skin.
MedLine Citation:
PMID:  3272749     Owner:  NLM     Status:  MEDLINE    
The proinflammatory effects of recombinant human interleukin-1 alpha (HRIL-1 alpha) have been determined in the skin of normal human volunteers. Intradermal injection of 10, 50 and 100 U HRIL-1 alpha produced dose-related erythema which first appeared at 2 h, was maximal around 24 h, persisted for up to 48 h, and was associated with oedema. Histological examination revealed dermal mononuclear cell infiltrates, which were accompanied by neutrophils at 4 and 8 h. Injection of heat-treated HRIL-1 alpha (100 U) produced no erythema or oedema. These results demonstrate the potent proinflammatory properties of HRIL-1 alpha in human skin.
P M Dowd; R D Camp; M W Greaves
Related Documents :
18648529 - Type i interferon: potential therapeutic target for psoriasis?
1743379 - The skin: an immunoreactive target organ during interleukin-2 administration?
22558139 - Cathepsin s deficiency results in abnormal accumulation of autophagosomes in macrophage...
22757679 - The clotting system - a major player in wound healing.
8983179 - A transgenic mouse model that recapitulates the clinical features of both neonatal and ...
20400709 - The mandatory role of il-10-producing and ox40 ligand-expressing mature langerhans cell...
7737289 - T cells expressing the gamma delta t cell receptor are not required for egg granuloma f...
9202289 - Ice/ced-3 family executes oligodendrocyte apoptosis by tumor necrosis factor.
8493539 - Induction of olfactory receptor sensitivity in mice.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Skin pharmacology : the official journal of the Skin Pharmacology Society     Volume:  1     ISSN:  1011-0283     ISO Abbreviation:  Skin Pharmacol.     Publication Date:  1988  
Date Detail:
Created Date:  1990-04-16     Completed Date:  1990-04-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8810069     Medline TA:  Skin Pharmacol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  30-7     Citation Subset:  IM    
Institute of Dermatology, United Medical School, St. Thomas' Hospital, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Sedimentation
C-Reactive Protein / metabolism
Dermatitis / etiology,  pathology*
Dose-Response Relationship, Drug
Injections, Intradermal
Interleukin-1 / administration & dosage,  pharmacology*
Leukocyte Count
Neutrophils / drug effects
Recombinant Proteins / administration & dosage,  pharmacology
Skin / pathology
Reg. No./Substance:
0/Interleukin-1; 0/Recombinant Proteins; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of a new method of assessing pruritus and antipruritic drugs.
Next Document:  Investigation of the skin thinning effect of prednicarbate and other corticoids in mouse skin.